Evidence map›Paper›PMID 20696828›Full record

ArticleInfection and immunity2010

Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier.

Longkun Zhu, Ravi Maruvada, Adam Sapirstein, Kafait U Malik, Marc Peters-Golden, Kwang Sik Kim

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuroprotective effects of CysLTR antagonist onExperimental and therapeutic medicine · 2022
    Article
  4. Article
  5. Article
  6. An ArcA-Modulated Small RNA in PathogenicFrontiers in microbiology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Longkun ZhuDivision of Pediatric Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Ravi Maruvada
Adam Sapirstein
Kafait U Malik
Marc Peters-Golden
Kwang Sik Kim
Johns Hopkins University · USJohns Hopkins Medicine · USUniversity of Michigan–Ann Arbor · USUniversity of Tennessee Health Science Center · US

Funding

PATHOGENESIS OF NEONATAL MENINGITISR01NS026310 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KIM, KWANG S · 1988 to 2008
$3.6M
Leukotrienes and blood-brain barrierR01AI084984 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KIM, KWANG S · 2010 to 2014
$2.0M
E. coli invasion of brain endothelial cellsR56NS026310 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KIM, KWANG S · 2009 to 2009
$410k
NIAID NIH HHS AI84984NIAID NIH HHS R01 AI084984NINDS NIH HHS NS26310NINDS NIH HHS R01 NS026310NINDS NIH HHS R56 NS026310
6 · The paper itself

Abstract

Escherichia coli K1 meningitis occurs following penetration of the blood-brain barrier, but the underlying mechanisms involved in E. coli penetration of the blood-brain barrier remain incompletely understood. We have previously shown that host cytosolic phospholipase A(2)α (cPLA(2)α) contributes to E. coli invasion of human brain microvascular endothelial cells (HBMEC), which constitute the blood-brain barrier, but the underlying mechanisms remain unclear. cPLA(2)α selectively liberates arachidonic acid from membrane phospholipids. Here, we provide the first direct evidence that host 5-lipoxygenase and lipoxygenase products of arachidonic acid, cysteinyl leukotrienes (LTs), contribute to E. coli K1 invasion of HBMEC and penetration into the brain, and their contributions involve protein kinase C alpha (PKCα). These findings demonstrate that arachidonic acid metabolism regulates E. coli penetration of the blood-brain barrier, and studies are needed to further elucidate the mechanisms involved with metabolic products of arachidonic acid for their contribution to E. coli invasion of the blood-brain barrier.

Indexed as

AnimalsArachidonate 5-LipoxygenaseArachidonic AcidBlood-Brain BarrierBrainEndothelial CellsEscherichia coliGroup IV Phospholipases A2HumansLeukotrienesMiceMice, KnockoutProtein Kinase C-alphaArachidonate 5-LipoxygenaseArachidonic AcidGroup IV Phospholipases A2LeukotrienesProtein Kinase C-alpha

Identifiers

PMID20696828
PMCPMC2950368
OpenAlexW1977126301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.